SAGE News and Press, Sage Therapeutics Inc. From 04/17/24

2024-04-17 10:00:55 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Short interest in S&P 500 health stocks rises, Moderna among m...

A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) fell 0.7% to $0.177 on volume of 56,661,669 shares INVO BioScience Inc. (INVO) rose 233.6% to $2.535 on volume of 49,222,014 shares WiSA Technologies Inc. (WISA) rose 51.8% to $9.26 on volume of 27,894,316 sh...

2024-04-17 07:40:30 ET More on Sage Therapeutics SAGE Therapeutics, Inc. (SAGE) Q4 2023 Earnings Call Transcript Sage Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation Sizing Up Sage Therapeutics Sage Therapeutics GAAP EPS of -$0.55 beats by $...

- In the Phase 2 PRECEDENT Study, dalzanemdor (SAGE-718) did not show statistically significant differences versus placebo on the primary endpoint in patients with mild cognitive impairment in Parkinson’s disease - Dalzanemdor (SAGE-718) was generally well-tolerated and there...

Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, today announced that it will host a live webcast on Thursday, April 25, 2024 at 8:00 a.m. ET to review first quarter 2024 financial results and discuss recent business u...

2024-04-04 13:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-03-15 10:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in March: TD Cowen 44 th Annual Health Care Conference (Boston, ...

2024-02-15 13:15:03 ET RBC Capital analyst issues SECTOR PERFORM recommendation for SAGE on February 15, 2024 12:59PM ET. The previous analyst recommendation was Sector Perform. SAGE was trading at $25.645 at issue of the analyst recommendation. The overall analyst conse...

2024-02-14 13:00:04 ET SAGE Therapeutics, Inc. (SAGE) Q4 2023 Earnings Conference Call February 14, 2024, 8:00 a.m. ET Company Participants Barry Greene - President, CEO & Director Kimi Iguchi - CFO & Treasurer Laura Gault - Chief Medical Officer Chri...